KINGFA NSE filing

Kingfa Science & Technology (India) reports reduced standalone losses for Q2 and H1 FY2026

The RealCase readMedium impact Positive

Kingfa Science & Technology (India) Limited's Board approved unaudited standalone financial results for Q2 and H1 FY2026, showing significant reduction in net losses.

Why it matters

The announcement details the company's latest financial performance, showing a positive trend of reduced losses, which is a key indicator for investors, though the company is still reporting a net loss.

The market read

The company reported a significant reduction in net loss for both the quarter and half-year ended September 30, 2025, alongside a quarter-on-quarter increase in revenue, indicating an improving financial performance.

Kingfa Science & Technology (India) Limited announced that its Board of Directors, at a meeting held on November 12, 2025, approved the unaudited standalone financial results for the quarter and half year ended September 30, 2025. The key financial highlights are as follows: * For the quarter ended September 30, 2025: * Revenue from operations stood at ₹4,490.71 crore, up from ₹4,226.59 crore in the corresponding quarter of the previous year. * Net Loss for the quarter significantly reduced to (₹52.23) crore, compared to a net loss of (₹107.83) crore in Q2 FY2025. * Earnings Per Share (EPS) improved to (₹0.66) from (₹1.36) in Q2 FY2025. * For the half year ended September 30, 2025: * Revenue from operations was ₹8,487.55 crore, a slight decrease from ₹8,518.44 crore in the previous half year. * Net Loss for the half year substantially decreased to (₹97.57) crore, from a net loss of (₹175.86) crore in H1 FY2025. * Earnings Per Share (EPS) improved to (₹1.23) from (₹2.22) in H1 FY2025.

These financial results were published in The Financial Express (English) and Makkal Kural (Tamil) on November 13, 2025, and are also available on the company's website.

Filing to action

What to do with a filing like this

Kingfa Science & Technology (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Kingfa Science & Technology (India) Limited. Read the original for the full detail.

View original filing